The CASTLE Online Sleep Intervention may help reduce sleep onset latency for children with epilepsy when paired with standard ...

Epigenetic age acceleration appears to be associated with worse neurocognitive function for those that survive childhood ...

Below is a review of novel drug and biological products approved by the Food and Drug Administration (FDA) in 2025. The list includes several groundbreaking therapies that are expected to change the ...

Multiple adverse prenatal exposures linked to altered developmental trajectories of psychopathology and cortical maturation ...

For older men, any amount, frequency, or severity of back pain appears to be predictive of subsequent sleep problems.

Menopause hormone therapy use does not appear to be associated with an increased risk for dementia for postmenopausal women.

Evidence from observational studies shows that endometriosis and migraine frequently co-occur, with each condition linked to ...

For those looking to lower stress levels this year, hitting the gym might be the best strategy, especially for woman.

Cannabis use may impair the ability of people with multiple sclerosis to accurately self-assess their cognitive performance.

Social disruption from the COVID-19 pandemic is linked to increased odds of substance use in adolescents with chronic pain.

A multimodal sleep foundation model based on polysomnography data can predict the risk for multiple conditions, including dementia.

Clinical outcomes from routine practice confirm ocrelizumab effectiveness in relapsing MS, with low rates of disability worsening over 4 years.